Tosoh Bioscience, Inc. Sustainability Profile
Tosoh Bioscience, Inc., a leading player in the biotechnology sector, is headquartered in the United States, with significant operations across Europe and Asia. Founded in 2000, the company has established itself as a key provider of innovative solutions in the fields of chromatography, mass spectrometry, and bioseparation. Tosoh Bioscience is renowned for its high-quality products, including advanced chromatographic resins and analytical instruments, which are designed to enhance the efficiency and accuracy of laboratory processes. The company’s commitment to research and development has positioned it as a trusted partner in the pharmaceutical and biopharmaceutical industries. With a strong market presence and a reputation for excellence, Tosoh Bioscience continues to achieve notable milestones, contributing to advancements in life sciences and ensuring the highest standards in analytical performance.
DitchCarbon Score
How does Tosoh Bioscience, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Tosoh Bioscience, Inc.'s score of 60 is higher than 79% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Tosoh Bioscience, Inc., headquartered in the US, currently does not report specific carbon emissions data for the most recent year, as indicated by the absence of emissions figures. The company is a current subsidiary of Tosoh Corporation, which may influence its climate commitments and reporting practices. While there are no documented reduction targets or specific climate pledges from Tosoh Bioscience, it is important to note that emissions data and performance metrics may be cascaded from its parent company, Tosoh Corporation. This relationship suggests that any climate initiatives or targets may align with the broader strategies of the parent organisation. As of now, Tosoh Bioscience has not publicly committed to specific science-based targets or initiatives such as those outlined by the Science Based Targets initiative (SBTi) or the Carbon Disclosure Project (CDP). The lack of detailed emissions data and reduction commitments highlights an opportunity for the company to enhance its transparency and accountability in addressing climate change. In summary, while Tosoh Bioscience, Inc. does not currently provide specific emissions data or reduction targets, its affiliation with Tosoh Corporation may play a role in shaping its future climate commitments and sustainability strategies.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|
| Scope 1 | 7,705,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
| Scope 2 | 438,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | 6,051,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
How Carbon Intensive is Tosoh Bioscience, Inc.'s Industry?
How Carbon Intensive is Tosoh Bioscience, Inc.'s Location?
Tosoh Bioscience, Inc.'s Scope 3 Categories Breakdown
Tosoh Bioscience, Inc.'s Scope 3 emissions, which decreased by 1% last year and decreased by approximately 4% since 2017, demonstrating supply chain emissions tracking. A significant portion of their carbon footprint comes from suppliers and value chain emissions, with Scope 3 emissions accounting for 43% of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 47% of Scope 3 emissions.
Top Scope 3 Categories
Tosoh Bioscience, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Tosoh Bioscience, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
